Biotechnology
The Biotechnology industry has a total of 604 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.23 billion.
Market Cap
1.12T
Revenue
105.23B
Profits
-42.06B
PE Ratio
n/a
Profit Margin
-39.98%
Dividend Yield
0.04%
604 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.14B | 0.29% | 1,178,366 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.62B | 2.84% | 1,153,882 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 54.51B | 2.02% | 1,284,748 | 3.21B |
| 4 | ARGX | argenx SE | 54.44B | -0.07% | 303,845 | 3.68B |
| 5 | INSM | Insmed Incorporated | 41.64B | 2.84% | 2,282,839 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 35.50B | -0.57% | 189,917 | 4.97B |
| 7 | BNTX | BioNTech SE | 23.08B | 0.27% | 1,185,056 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.40B | 1.44% | 4,090,236 | 2.35B |
| 9 | GMAB | Genmab A/S | 19.82B | 3.39% | 2,078,466 | 3.85B |
| 10 | INCY | Incyte Corporation | 18.87B | 0.98% | 1,836,076 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.18B | 0.81% | 2,023,990 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 14.84B | 5.43% | 17,636,331 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 14.27B | 1.88% | 1,705,150 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.87B | 0.28% | 1,648,359 | - |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.98B | 3.41% | 292,477 | 740.64M |
| 16 | ASND | Ascendis Pharma A/S | 12.84B | 4.43% | 1,531,945 | 758.59M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.82B | 0.65% | 2,052,200 | 966.96M |
| 18 | MRNA | Moderna, Inc. | 11.58B | 2.07% | 8,158,760 | 2.23B |
| 19 | EXEL | Exelixis, Inc. | 11.14B | 0.78% | 2,794,345 | 2.29B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.79B | 0.35% | 1,812,020 | 20.87M |
| 21 | ABVX | ABIVAX Société Anonyme | 10.29B | 4.36% | 2,698,633 | 7.07M |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.18B | -1.32% | 1,831,122 | 3.09B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.02B | -0.05% | 1,142,177 | 4.16B |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.62B | 2.83% | 2,829,387 | 829.45M |
| 25 | TECH | Bio-Techne Corporation | 9.39B | -0.94% | 1,479,806 | 1.22B |
| 26 | CORT | Corcept Therapeutics Incorporated | 9.17B | 2.13% | 942,339 | 741.17M |
| 27 | NUVL | Nuvalent, Inc. | 8.22B | 0.09% | 583,310 | - |
| 28 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.85B | 12.26% | 3,420,338 | 174.33M |
| 29 | AXSM | Axsome Therapeutics, Inc. | 7.50B | -0.34% | 276,799 | 561.26M |
| 30 | CAI | Caris Life Sciences, Inc. | 7.49B | -2.07% | 2,020,662 | 649.06M |
| 31 | CYTK | Cytokinetics, Incorporated | 7.43B | 0.75% | 1,750,075 | 87.21M |
| 32 | MRUS | Merus N.V. | 7.33B | -0.14% | 1,099,521 | 56.61M |
| 33 | HALO | Halozyme Therapeutics, Inc. | 7.28B | -1.20% | 5,891,070 | 1.24B |
| 34 | KRYS | Krystal Biotech, Inc. | 7.16B | 2.94% | 258,569 | 373.16M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 7.02B | -2.31% | 1,398,467 | 43.74M |
| 36 | CDTX | Cidara Therapeutics, Inc. | 6.92B | 0.27% | 770,522 | 302.00K |
| 37 | PRAX | Praxis Precision Medicines, Inc. | 6.68B | 2.18% | 514,149 | 7.46M |
| 38 | COGT | Cogent Biosciences, Inc. | 6.09B | 2.22% | 2,831,644 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 6.06B | 1.81% | 723,378 | 1.78B |
| 40 | PCVX | Vaxcyte, Inc. | 5.84B | 2.53% | 1,151,158 | - |
| 41 | PTGX | Protagonist Therapeutics, Inc. | 5.77B | 0.95% | 800,761 | 209.22M |
| 42 | CRSP | CRISPR Therapeutics AG | 5.54B | 0.87% | 1,348,791 | 38.34M |
| 43 | BLTE | Belite Bio, Inc | 5.24B | 2.21% | 555,193 | - |
| 44 | APGE | Apogee Therapeutics, Inc. | 5.16B | 0.59% | 912,920 | - |
| 45 | TERN | Terns Pharmaceuticals, Inc. | 5.01B | 5.56% | 5,755,253 | - |
| 46 | ADMA | ADMA Biologics, Inc. | 4.85B | 2.00% | 1,923,687 | 488.56M |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.78B | 3.95% | 1,812,348 | - |
| 48 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.68B | 2.60% | 743,287 | 1.54M |
| 49 | TGTX | TG Therapeutics, Inc. | 4.68B | 4.58% | 1,734,305 | 531.90M |
| 50 | CELC | Celcuity Inc. | 4.66B | -1.04% | 872,045 | - |
| 51 | ACAD | ACADIA Pharmaceuticals Inc. | 4.51B | -0.48% | 940,497 | 1.05B |
| 52 | IMVT | Immunovant, Inc. | 4.35B | 5.31% | 6,656,859 | - |
| 53 | LEGN | Legend Biotech Corporation | 4.25B | -1.50% | 1,598,193 | 909.05M |
| 54 | VKTX | Viking Therapeutics, Inc. | 4.21B | -0.85% | 2,022,987 | - |
| 55 | ACLX | Arcellx, Inc. | 4.20B | 0.99% | 1,135,254 | 35.90M |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 4.10B | 1.57% | 1,118,328 | 35.24M |
| 57 | GPCR | Structure Therapeutics Inc. | 4.09B | -2.18% | 2,069,650 | - |
| 58 | CNTA | Centessa Pharmaceuticals plc | 3.97B | -8.08% | 4,058,202 | 15.00M |
| 59 | ARQT | Arcutis Biotherapeutics, Inc. | 3.61B | -1.01% | 2,412,392 | 317.93M |
| 60 | IRON | Disc Medicine, Inc. | 3.53B | 0.81% | 624,131 | - |
| 61 | RARE | Ultragenyx Pharmaceutical Inc. | 3.49B | 0.56% | 1,321,276 | 630.60M |
| 62 | TARS | Tarsus Pharmaceuticals, Inc. | 3.47B | 0.53% | 388,240 | 366.10M |
| 63 | MIRM | Mirum Pharmaceuticals, Inc. | 3.38B | 1.62% | 786,237 | 471.79M |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.37B | 0.51% | 856,352 | 7.50M |
| 65 | CGON | CG Oncology, Inc. | 3.36B | -0.31% | 466,344 | 2.17M |
| 66 | APLS | Apellis Pharmaceuticals, Inc. | 3.16B | 1.15% | 1,806,108 | 1.02B |
| 67 | TVTX | Travere Therapeutics, Inc. | 3.13B | 1.83% | 1,508,933 | 435.83M |
| 68 | OCUL | Ocular Therapeutix, Inc. | 3.13B | -4.80% | 3,609,282 | 55.78M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.11B | -1.02% | 1,148,770 | 240.00M |
| 70 | VRDN | Viridian Therapeutics, Inc. | 3.11B | -0.09% | 872,776 | 70.79M |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.10B | -5.54% | 193,242 | 664.23M |
| 72 | FOLD | Amicus Therapeutics, Inc. | 3.05B | 0.51% | 3,848,407 | 598.70M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 2.94B | -0.24% | 585,633 | 214.83M |
| 74 | VERA | Vera Therapeutics, Inc. | 2.94B | 3.79% | 1,118,710 | - |
| 75 | MLYS | Mineralys Therapeutics, Inc. | 2.85B | -0.41% | 1,564,192 | - |
| 76 | NUVB | Nuvation Bio Inc. | 2.84B | 5.48% | 7,080,377 | 26.75M |
| 77 | LQDA | Liquidia Corporation | 2.84B | -0.28% | 930,243 | 69.22M |
| 78 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.82B | 0.61% | 1,737,249 | 578.20M |
| 79 | AAPG | Ascentage Pharma Group International | 2.80B | 1.73% | 1,375 | 54.52M |
| 80 | WVE | Wave Life Sciences Ltd. | 2.80B | -17.20% | 15,448,409 | 109.23M |
| 81 | DYN | Dyne Therapeutics, Inc. | 2.77B | -1.37% | 3,283,973 | - |
| 82 | BEAM | Beam Therapeutics Inc. | 2.72B | 0.40% | 1,396,240 | 55.70M |
| 83 | SYRE | Spyre Therapeutics, Inc. | 2.67B | -0.87% | 666,850 | - |
| 84 | SLNO | Soleno Therapeutics, Inc. | 2.66B | -1.02% | 2,581,061 | 98.68M |
| 85 | DNLI | Denali Therapeutics Inc. | 2.55B | -1.14% | 2,999,115 | - |
| 86 | OLMA | Olema Pharmaceuticals, Inc. | 2.48B | 2.93% | 3,217,386 | - |
| 87 | EWTX | Edgewise Therapeutics, Inc. | 2.48B | -1.31% | 1,266,869 | - |
| 88 | RXRX | Recursion Pharmaceuticals, Inc. | 2.38B | -3.98% | 13,570,742 | 43.69M |
| 89 | ADPT | Adaptive Biotechnologies Corporation | 2.35B | -2.03% | 2,298,214 | 252.75M |
| 90 | MESO | Mesoblast Limited | 2.34B | -3.41% | 291,797 | 17.20M |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.28B | 0.81% | 545,593 | 825.94M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.28B | -2.03% | 4,775,544 | 2.41B |
| 93 | ZBIO | Zenas BioPharma, Inc. | 2.16B | 2.84% | 209,734 | 15.00M |
| 94 | IBRX | ImmunityBio, Inc. | 2.16B | -4.78% | 8,346,475 | 82.56M |
| 95 | GLPG | Galapagos NV | 2.13B | 0.74% | 133,191 | 336.64M |
| 96 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | 2.65% | 1,180,409 | 265.81M |
| 97 | ZLAB | Zai Lab Limited | 1.98B | -2.52% | 755,750 | 441.63M |
| 98 | NRIX | Nurix Therapeutics, Inc. | 1.93B | -2.75% | 1,420,897 | 83.69M |
| 99 | MAZE | Maze Therapeutics, Inc. | 1.90B | 2.41% | 369,731 | 2.50M |
| 100 | VCEL | Vericel Corporation | 1.89B | -0.61% | 424,192 | 258.72M |
| 101 | STOK | Stoke Therapeutics, Inc. | 1.89B | -3.10% | 1,061,627 | 205.63M |
| 102 | ZYME | Zymeworks Inc. | 1.87B | -3.59% | 640,598 | 134.48M |
| 103 | SION | Sionna Therapeutics, Inc. | 1.86B | 1.19% | 241,212 | - |
| 104 | CLDX | Celldex Therapeutics, Inc. | 1.86B | -0.89% | 669,831 | 2.60M |
| 105 | IMCR | Immunocore Holdings plc | 1.81B | -0.64% | 269,162 | 379.59M |
| 106 | IMNM | Immunome, Inc. | 1.79B | -3.99% | 1,120,105 | 9.68M |
| 107 | DNTH | Dianthus Therapeutics, Inc. | 1.78B | -4.47% | 724,779 | 3.08M |
| 108 | MNKD | MannKind Corporation | 1.78B | -0.51% | 3,696,679 | 313.79M |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | -1.02% | 1,890,207 | 111.30M |
| 110 | TRVI | Trevi Therapeutics, Inc. | 1.69B | -7.06% | 2,707,393 | - |
| 111 | SVRA | Savara Inc. | 1.67B | 3.74% | 2,965,276 | - |
| 112 | ATAI | Atai Beckley N.V. | 1.61B | 2.08% | 1,851,288 | 3.02M |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 1.60B | -1.93% | 1,511,508 | 44.79M |
| 114 | TSHA | Taysha Gene Therapies, Inc. | 1.58B | 3.60% | 4,591,938 | 6.31M |
| 115 | CAPR | Capricor Therapeutics, Inc. | 1.57B | -5.20% | 1,842,768 | 11.13M |
| 116 | PHVS | Pharvaris N.V. | 1.56B | 1.27% | 232,925 | - |
| 117 | INVA | Innoviva, Inc. | 1.54B | - | 789,078 | 388.52M |
| 118 | BHVN | Biohaven Ltd. | 1.52B | 7.92% | 3,400,187 | - |
| 119 | UPB | Upstream Bio, Inc. | 1.48B | -4.19% | 661,765 | 2.80M |
| 120 | ORKA | Oruka Therapeutics, Inc. | 1.46B | -3.79% | 254,345 | - |
| 121 | FTRE | Fortrea Holdings Inc. | 1.44B | 2.71% | 1,823,163 | 2.76B |
| 122 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.44B | -1.21% | 1,808,652 | -665.00K |
| 123 | ARDX | Ardelyx, Inc. | 1.43B | -0.34% | 2,413,179 | 398.23M |
| 124 | RAPP | Rapport Therapeutics, Inc. | 1.37B | 0.38% | 231,611 | - |
| 125 | RLAY | Relay Therapeutics, Inc. | 1.35B | 2.64% | 1,871,344 | 8.36M |
| 126 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.33B | -3.71% | 1,108,073 | 42.34M |
| 127 | SANA | Sana Biotechnology, Inc. | 1.33B | 1.21% | 4,698,123 | - |
| 128 | PGEN | Precigen, Inc. | 1.28B | 3.13% | 2,241,318 | 6.31M |
| 129 | KOD | Kodiak Sciences Inc. | 1.28B | -1.75% | 560,081 | - |
| 130 | MBX | MBX Biosciences, Inc. | 1.28B | -1.35% | 823,783 | - |
| 131 | ANAB | AnaptysBio, Inc. | 1.27B | 1.85% | 485,193 | 169.47M |
| 132 | MNMD | Mind Medicine (MindMed) Inc. | 1.24B | 1.70% | 1,391,598 | - |
| 133 | QURE | uniQure N.V. | 1.23B | -1.94% | 3,093,986 | 15.75M |
| 134 | TNGX | Tango Therapeutics, Inc. | 1.23B | -0.76% | 1,709,327 | 66.50M |
| 135 | IMTX | Immatics N.V. | 1.22B | -0.20% | 639,315 | 99.45M |
| 136 | XNCR | Xencor, Inc. | 1.22B | -0.64% | 611,379 | 150.13M |
| 137 | TYRA | Tyra Biosciences, Inc. | 1.22B | 2.33% | 587,985 | - |
| 138 | ALMS | Alumis Inc. | 1.21B | -4.13% | 1,092,504 | 22.12M |
| 139 | OCS | Oculis Holding AG | 1.21B | 1.21% | 48,940 | 992.00K |
| 140 | INBX | Inhibrx Biosciences, Inc. | 1.20B | -2.72% | 112,718 | 1.40M |
| 141 | PHAR | Pharming Group N.V. | 1.19B | 1.43% | 15,758 | 362.27M |
| 142 | SEPN | Septerna, Inc. | 1.17B | 2.22% | 219,534 | 22.05M |
| 143 | XERS | Xeris Biopharma Holdings, Inc. | 1.16B | 1.01% | 2,145,779 | 266.14M |
| 144 | CVAC | CureVac N.V. | 1.15B | 0.20% | 506,264 | 83.00M |
| 145 | PVLA | Palvella Therapeutics, Inc. | 1.15B | -0.67% | 166,509 | - |
| 146 | NBTX | Nanobiotix S.A. | 1.13B | 3.11% | 51,407 | 11.93M |
| 147 | ABCL | AbCellera Biologics Inc. | 1.12B | -0.80% | 2,546,170 | 35.33M |
| 148 | ELVN | Enliven Therapeutics, Inc. | 1.11B | -6.94% | 1,187,348 | - |
| 149 | SPRY | ARS Pharmaceuticals, Inc. | 1.11B | 7.47% | 2,133,660 | 142.77M |
| 150 | NTLA | Intellia Therapeutics, Inc. | 1.11B | 1.92% | 3,067,838 | 57.53M |
| 151 | NVAX | Novavax, Inc. | 1.09B | -0.74% | 2,645,269 | 1.06B |
| 152 | GLUE | Monte Rosa Therapeutics, Inc. | 1.08B | -3.89% | 632,819 | 181.54M |
| 153 | MDXG | MiMedx Group, Inc. | 1.06B | 2.58% | 1,014,892 | 393.44M |
| 154 | URGN | UroGen Pharma Ltd. | 1.05B | 0.77% | 982,427 | 96.52M |
| 155 | NKTR | Nektar Therapeutics | 1.04B | -11.47% | 914,334 | 62.60M |
| 156 | BCAX | Bicara Therapeutics Inc. | 1.03B | -1.36% | 350,915 | - |
| 157 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.03B | -0.31% | 76,194 | - |
| 158 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | 0.14% | 423,989 | 147.19M |
| 159 | MLTX | MoonLake Immunotherapeutics | 1.00B | -3.70% | 2,235,373 | - |
| 160 | AVBP | ArriVent BioPharma, Inc. | 1.00B | -0.12% | 306,760 | - |
| 161 | RAPT | RAPT Therapeutics, Inc. | 977.64M | -3.66% | 194,296 | - |
| 162 | ERAS | Erasca, Inc. | 958.95M | 3.68% | 3,181,974 | - |
| 163 | CMPX | Compass Therapeutics, Inc. | 958.68M | 2.67% | 1,677,898 | 850.00K |
| 164 | MRVI | Maravai LifeSciences Holdings, Inc. | 948.67M | -0.54% | 1,247,554 | 192.44M |
| 165 | ORIC | ORIC Pharmaceuticals, Inc. | 943.70M | -3.10% | 760,477 | - |
| 166 | CRMD | CorMedix Inc. | 924.98M | 2.35% | 4,109,590 | 214.30M |
| 167 | JANX | Janux Therapeutics, Inc. | 923.87M | -1.41% | 1,542,717 | 10.00M |
| 168 | VIR | Vir Biotechnology, Inc. | 922.40M | 1.22% | 1,510,364 | 16.86M |
| 169 | KURA | Kura Oncology, Inc. | 910.20M | -2.61% | 1,475,059 | 104.03M |
| 170 | ABUS | Arbutus Biopharma Corporation | 898.15M | 1.74% | 1,452,276 | 14.61M |
| 171 | TBPH | Theravance Biopharma, Inc. | 895.89M | 0.40% | 807,789 | 80.33M |
| 172 | IOVA | Iovance Biotherapeutics, Inc. | 893.18M | -0.44% | 13,859,210 | 250.43M |
| 173 | GERN | Geron Corporation | 887.31M | 8.59% | 16,302,717 | 183.40M |
| 174 | MPLT | MapLight Therapeutics, Inc. | 876.32M | -1.62% | 225,570 | - |
| 175 | DAWN | Day One Biopharmaceuticals, Inc. | 864.53M | -1.06% | 1,056,068 | 133.67M |
| 176 | YDES | YD Bio Limited | 862.12M | -3.01% | 146,593 | 510.36K |
| 177 | GHRS | GH Research PLC | 856.01M | -2.89% | 321,204 | - |
| 178 | KALV | KalVista Pharmaceuticals, Inc. | 854.23M | 0.24% | 1,608,094 | 1.43M |
| 179 | IVA | Inventiva S.A. | 853.22M | 0.22% | 110,839 | 19.93M |
| 180 | GOSS | Gossamer Bio, Inc. | 837.87M | 3.72% | 4,279,719 | 44.05M |
| 181 | ARVN | Arvinas, Inc. | 807.30M | -3.16% | 1,283,957 | 312.30M |
| 182 | REPL | Replimune Group, Inc. | 774.24M | 0.51% | 1,948,968 | - |
| 183 | VALN | Valneva SE | 772.67M | 0.79% | 13,228 | 211.09M |
| 184 | LENZ | LENZ Therapeutics, Inc. | 766.60M | -2.16% | 851,459 | 17.50M |
| 185 | RIGL | Rigel Pharmaceuticals, Inc. | 763.26M | 2.01% | 402,517 | 282.08M |
| 186 | PRME | Prime Medicine, Inc. | 755.95M | -1.39% | 2,059,647 | 5.98M |
| 187 | ANNX | Annexon, Inc. | 751.24M | 2.86% | 3,393,146 | - |
| 188 | OMER | Omeros Corporation | 750.84M | -5.78% | 1,566,976 | - |
| 189 | ATXS | Astria Therapeutics, Inc. | 736.97M | -0.46% | 1,056,893 | 706.00K |
| 190 | CGEM | Cullinan Therapeutics, Inc. | 731.36M | -0.64% | 891,200 | - |
| 191 | DBVT | DBV Technologies S.A. | 728.56M | -2.87% | 493,169 | 5.50M |
| 192 | VSTM | Verastem, Inc. | 727.83M | -5.79% | 1,222,690 | 13.38M |
| 193 | GYRE | Gyre Therapeutics, Inc. | 715.31M | -6.97% | 54,278 | 107.27M |
| 194 | LXEO | Lexeo Therapeutics, Inc. | 715.28M | 0.72% | 744,692 | - |
| 195 | LYEL | Lyell Immunopharma, Inc. | 708.90M | 6.81% | 92,449 | 41.00K |
| 196 | MGTX | MeiraGTx Holdings plc | 701.88M | 3.93% | 471,799 | 27.42M |
| 197 | DRUG | Bright Minds Biosciences Inc. | 693.39M | 5.47% | 142,859 | - |
| 198 | FULC | Fulcrum Therapeutics, Inc. | 692.72M | -7.25% | 3,002,664 | 80.00M |
| 199 | CTMX | CytomX Therapeutics, Inc. | 687.91M | 4.10% | 1,390,607 | 113.63M |
| 200 | JBIO | Jade Biosciences, Inc. | 682.70M | 10.01% | 459,955 | - |
| 201 | PROK | ProKidney Corp. | 667.85M | 2.30% | 939,410 | 744.00K |
| 202 | KROS | Keros Therapeutics, Inc. | 660.81M | -0.69% | 542,468 | 246.72M |
| 203 | RGNX | REGENXBIO Inc. | 650.51M | -1.61% | 593,150 | 161.32M |
| 204 | CRVS | Corvus Pharmaceuticals, Inc. | 627.33M | -1.06% | 968,614 | - |
| 205 | FDMT | 4D Molecular Therapeutics, Inc. | 623.92M | 0.83% | 562,305 | 120.00K |
| 206 | VTYX | Ventyx Biosciences, Inc. | 606.55M | -2.19% | 885,102 | - |
| 207 | ENGN | enGene Holdings Inc. | 596.50M | 11.36% | 242,261 | - |
| 208 | EVMN | Evommune, Inc. | 592.23M | 0.41% | 265,185 | 13.00M |
| 209 | ABSI | Absci Corporation | 577.43M | -3.27% | 3,381,117 | 2.82M |
| 210 | ASMB | Assembly Biosciences, Inc. | 567.52M | 0.03% | 60,314 | 37.19M |
| 211 | DNA | Ginkgo Bioworks Holdings, Inc. | 562.68M | 1.23% | 975,414 | 180.61M |
| 212 | ALT | Altimmune, Inc. | 557.19M | -1.66% | 2,780,191 | 20.00K |
| 213 | PRTA | Prothena Corporation plc | 556.06M | 4.66% | 693,399 | 11.79M |
| 214 | IVVD | Invivyd, Inc. | 554.83M | -5.18% | 3,350,267 | 50.04M |
| 215 | NAGE | Niagen Bioscience, Inc. | 530.99M | 0.76% | 791,818 | 124.71M |
| 216 | DSGN | Design Therapeutics, Inc. | 526.35M | -1.91% | 173,018 | - |
| 217 | ADCT | ADC Therapeutics SA | 517.81M | 4.24% | 1,112,596 | 75.21M |
| 218 | BCYC | Bicycle Therapeutics plc | 516.79M | -0.93% | 197,253 | 28.34M |
| 219 | MNPR | Monopar Therapeutics Inc. | 514.89M | -1.50% | 113,008 | - |
| 220 | LBRX | LB Pharmaceuticals Inc | 511.80M | -5.29% | 187,829 | - |
| 221 | DMAC | DiaMedica Therapeutics Inc. | 486.40M | -0.11% | 471,211 | - |
| 222 | LXRX | Lexicon Pharmaceuticals, Inc. | 479.69M | - | 1,062,257 | 70.86M |
| 223 | ZVRA | Zevra Therapeutics, Inc. | 472.34M | -0.71% | 996,468 | 84.39M |
| 224 | SLDB | Solid Biosciences Inc. | 457.33M | -0.17% | 682,990 | - |
| 225 | ANRO | Alto Neuroscience, Inc. | 456.05M | 2.80% | 233,386 | - |
| 226 | NBP | NovaBridge Biosciences | 451.84M | -4.16% | 252,282 | - |
| 227 | BNTC | Benitec Biopharma Inc. | 438.85M | 1.17% | 291,306 | - |
| 228 | AUTL | Autolus Therapeutics plc | 423.17M | 3.92% | 2,506,876 | 51.13M |
| 229 | VTVT | vTv Therapeutics Inc. | 423.14M | -0.90% | 7,071 | 17.00K |
| 230 | DRTS | Alpha Tau Medical Ltd. | 422.91M | -1.98% | 308,327 | - |
| 231 | LCTX | Lineage Cell Therapeutics, Inc. | 414.38M | -1.72% | 643,691 | 10.82M |
| 232 | AURA | Aura Biosciences, Inc. | 413.41M | 0.62% | 163,421 | - |
| 233 | ENTA | Enanta Pharmaceuticals, Inc. | 408.12M | -1.60% | 254,763 | 65.32M |
| 234 | OCGN | Ocugen, Inc. | 406.02M | 5.69% | 4,022,807 | 5.37M |
| 235 | FBRX | Forte Biosciences, Inc. | 403.88M | 11.85% | 67,543 | - |
| 236 | IMRX | Immuneering Corporation | 400.33M | 0.65% | 822,631 | - |
| 237 | TENX | Tenax Therapeutics, Inc. | 399.62M | 0.31% | 90,897 | - |
| 238 | PRTC | PureTech Health plc | 398.90M | 0.59% | 900 | 6.39M |
| 239 | PEPG | PepGen Inc. | 394.61M | -1.88% | 360,936 | - |
| 240 | VNDA | Vanda Pharmaceuticals Inc. | 390.04M | -2.22% | 1,691,379 | 212.07M |
| 241 | CLLS | Cellectis S.A. | 388.49M | 1.75% | 219,268 | 82.55M |
| 242 | TRDA | Entrada Therapeutics, Inc. | 387.66M | 2.08% | 211,888 | 61.52M |
| 243 | CTNM | Contineum Therapeutics, Inc. | 381.42M | 4.39% | 79,860 | - |
| 244 | RCKT | Rocket Pharmaceuticals, Inc. | 373.37M | -4.96% | 8,113,662 | - |
| 245 | IMMP | Immutep Limited | 368.38M | 5.20% | 744,110 | 3.31M |
| 246 | GALT | Galectin Therapeutics Inc. | 368.14M | 4.01% | 706,353 | - |
| 247 | AVXL | Anavex Life Sciences Corp. | 367.22M | 0.74% | 1,566,228 | - |
| 248 | KYTX | Kyverna Therapeutics, Inc. | 366.14M | 2.20% | 213,881 | - |
| 249 | TECX | Tectonic Therapeutic, Inc. | 364.41M | -3.42% | 256,866 | - |
| 250 | ACRS | Aclaris Therapeutics, Inc. | 364.04M | 2.75% | 1,966,680 | 15.74M |
| 251 | MREO | Mereo BioPharma Group plc | 358.05M | -2.60% | 2,116,403 | 500.00K |
| 252 | CADL | Candel Therapeutics, Inc. | 355.19M | 11.55% | 3,491,190 | - |
| 253 | NBY | NovaBay Pharmaceuticals, Inc. | 354.09M | 16.12% | 1,696,195 | 10.30M |
| 254 | AVTX | Avalo Therapeutics, Inc. | 353.79M | -2.21% | 190,012 | 192.00K |
| 255 | NMRA | Neumora Therapeutics, Inc. | 351.77M | -0.96% | 476,399 | - |
| 256 | ALLO | Allogene Therapeutics, Inc. | 348.33M | 4.73% | 2,874,831 | 22.00K |
| 257 | LRMR | Larimar Therapeutics, Inc. | 344.07M | 2.03% | 1,208,788 | - |
| 258 | AARD | Aardvark Therapeutics, Inc. | 339.88M | 11.66% | 333,199 | - |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 339.25M | -0.26% | 573,655 | 33.98M |
| 260 | NGNE | Neurogene Inc. | 329.31M | 2.41% | 102,430 | 925.00K |
| 261 | XOMA | XOMA Royalty Corporation | 328.65M | -22.76% | 289,600 | 47.11M |
| 262 | PALI | Palisade Bio, Inc. | 327.81M | 4.76% | 8,888,282 | - |
| 263 | EPRX | Eupraxia Pharmaceuticals Inc. | 325.66M | 1.59% | 160,445 | - |
| 264 | ACIU | AC Immune SA | 318.60M | 15.41% | 19,953,015 | 5.48M |
| 265 | GUTS | Fractyl Health, Inc. | 315.20M | -1.71% | 2,492,417 | 3.00K |
| 266 | CYBN | Cybin Inc. | 314.39M | 5.53% | 1,017,684 | - |
| 267 | OABI | OmniAb, Inc. | 310.94M | 8.00% | 923,573 | 21.09M |
| 268 | TARA | Protara Therapeutics, Inc. | 310.30M | 4.70% | 1,663,042 | - |
| 269 | RLMD | Relmada Therapeutics, Inc. | 307.27M | -5.20% | 1,793,246 | - |
| 270 | SLN | Silence Therapeutics plc | 304.19M | 2.88% | 145,789 | 25.83M |
| 271 | MIST | Milestone Pharmaceuticals Inc. | 299.67M | 10.49% | 7,533,644 | - |
| 272 | CBIO | Crescent Biopharma, Inc. | 299.30M | 5.66% | 121,455 | - |
| 273 | ABEO | Abeona Therapeutics Inc. | 299.14M | 0.91% | 1,330,259 | 400.00K |
| 274 | PBYI | Puma Biotechnology, Inc. | 288.74M | 2.50% | 369,504 | 212.00M |
| 275 | SLS | SELLAS Life Sciences Group, Inc. | 286.31M | 2.55% | 5,862,428 | - |
| 276 | CAMP | Camp4 Therapeutics Corporation | 281.76M | 5.07% | 217,437 | 3.80M |
| 277 | ALDX | Aldeyra Therapeutics, Inc. | 276.15M | -4.18% | 1,136,359 | - |
| 278 | PYXS | Pyxis Oncology, Inc. | 274.59M | 2.80% | 344,694 | 2.82M |
| 279 | ZURA | Zura Bio Limited | 262.69M | 8.60% | 818,471 | - |
| 280 | OBIO | Orchestra BioMed Holdings, Inc. | 258.04M | -2.14% | 144,471 | 2.82M |
| 281 | FENC | Fennec Pharmaceuticals Inc. | 255.81M | 0.67% | 60,400 | 38.79M |
| 282 | FHTX | Foghorn Therapeutics Inc. | 253.35M | 0.67% | 137,681 | 24.52M |
| 283 | HRTX | Heron Therapeutics, Inc. | 251.21M | - | 1,664,996 | 155.10M |
| 284 | NAUT | Nautilus Biotechnology, Inc. | 250.08M | -2.94% | 186,627 | - |
| 285 | EDIT | Editas Medicine, Inc. | 249.90M | -1.54% | 2,129,210 | 46.38M |
| 286 | ACHV | Achieve Life Sciences, Inc. | 249.67M | 1.74% | 397,773 | - |
| 287 | AVIR | Atea Pharmaceuticals, Inc. | 249.22M | 0.95% | 424,174 | - |
| 288 | PRQR | ProQR Therapeutics N.V. | 248.61M | 5.83% | 1,068,858 | 18.86M |
| 289 | IMMX | Immix Biopharma, Inc. | 247.80M | 9.66% | 1,967,651 | - |
| 290 | VOR | Vor Biopharma Inc. | 247.58M | 17.42% | 3,324,434 | - |
| 291 | MDWD | MediWound Ltd. | 246.94M | 0.47% | 51,213 | 20.93M |
| 292 | CCCC | C4 Therapeutics, Inc. | 246.16M | -1.55% | 921,392 | 30.11M |
| 293 | HUMA | Humacyte, Inc. | 245.33M | 3.15% | 3,341,132 | 1.57M |
| 294 | QNCX | Quince Therapeutics, Inc. | 245.00M | 10.28% | 1,439,738 | - |
| 295 | VYGR | Voyager Therapeutics, Inc. | 244.92M | -0.34% | 412,872 | 31.32M |
| 296 | TNXP | Tonix Pharmaceuticals Holding Corp. | 231.17M | -0.61% | 292,010 | 10.30M |
| 297 | CABA | Cabaletta Bio, Inc. | 227.19M | -2.48% | 1,467,610 | - |
| 298 | TNYA | Tenaya Therapeutics, Inc. | 226.45M | -2.86% | 3,028,847 | - |
| 299 | RNAC | Cartesian Therapeutics, Inc. | 219.73M | 7.64% | 177,757 | 1.09M |
| 300 | ARCT | Arcturus Therapeutics Holdings Inc. | 213.66M | -1.96% | 522,941 | 97.60M |
| 301 | ARMP | Armata Pharmaceuticals, Inc. | 209.62M | 1.76% | 18,982 | 5.05M |
| 302 | SGMT | Sagimet Biosciences Inc. | 205.86M | 0.16% | 407,856 | - |
| 303 | STTK | Shattuck Labs, Inc. | 204.39M | - | 870,268 | 1.00M |
| 304 | TLSA | Tiziana Life Sciences Ltd | 204.38M | -4.44% | 145,761 | - |
| 305 | SRZN | Surrozen, Inc. | 204.09M | -0.58% | 136,803 | 3.60M |
| 306 | NVCT | Nuvectis Pharma, Inc. | 194.16M | 2.57% | 99,983 | - |
| 307 | DWTX | Dogwood Therapeutics, Inc. | 190.85M | 7.36% | 21,102 | - |
| 308 | NTHI | NeOnc Technologies Holdings, Inc. | 182.47M | -0.85% | 39,454 | 59.99K |
| 309 | IPHA | Innate Pharma S.A. | 180.69M | - | 5,873 | 14.84M |
| 310 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 179.36M | -5.65% | 5,026,876 | - |
| 311 | RANI | Rani Therapeutics Holdings, Inc. | 178.64M | -5.77% | 2,956,112 | 1.20M |
| 312 | IKT | Inhibikase Therapeutics, Inc. | 178.60M | 3.04% | 490,322 | 1.00 |
| 313 | CRBU | Caribou Biosciences, Inc. | 173.85M | -2.11% | 1,054,229 | 9.30M |
| 314 | CHRS | Coherus Oncology, Inc. | 172.85M | 7.52% | 1,130,413 | 277.73M |
| 315 | ETHZ | ETHZilla Corporation | 172.45M | -16.18% | 2,174,245 | 4.11M |
| 316 | ACTU | Actuate Therapeutics, Inc. | 171.77M | -2.76% | 87,892 | - |
| 317 | SABS | SAB Biotherapeutics, Inc. | 170.91M | -3.23% | 112,752 | 114.70K |
| 318 | IRD | Opus Genetics, Inc. | 168.27M | -2.40% | 347,548 | 14.63M |
| 319 | CRDF | Cardiff Oncology, Inc. | 166.72M | 1.02% | 1,327,982 | 501.00K |
| 320 | GNLX | Genelux Corporation | 165.52M | -2.44% | 77,387 | 8.00K |
| 321 | ALEC | Alector, Inc. | 159.36M | 12.31% | 4,998,035 | 69.05M |
| 322 | MOLN | Molecular Partners AG | 158.67M | 4.67% | 1,323 | 856.30K |
| 323 | ANIX | Anixa Biosciences, Inc. | 158.00M | -6.43% | 2,347,024 | - |
| 324 | BDTX | Black Diamond Therapeutics, Inc. | 157.25M | 3.37% | 1,092,667 | 70.00M |
| 325 | CLYM | Climb Bio, Inc. | 156.82M | 10.58% | 1,174,964 | - |
| 326 | GLSI | Greenwich LifeSciences, Inc. | 156.14M | 11.47% | 267,391 | - |
| 327 | VTGN | Vistagen Therapeutics, Inc. | 156.01M | -12.80% | 1,464,423 | 721.00K |
| 328 | KLRS | Kalaris Therapeutics, Inc. | 155.79M | 10.04% | 154,293 | - |
| 329 | MCRB | Seres Therapeutics, Inc. | 155.24M | 1.06% | 68,285 | 351.00K |
| 330 | SGMO | Sangamo Therapeutics, Inc. | 154.48M | -4.87% | 4,191,799 | 32.88M |
| 331 | CDXS | Codexis, Inc. | 154.45M | -6.04% | 1,117,699 | 52.93M |
| 332 | SAVA | Cassava Sciences, Inc. | 152.17M | -3.37% | 650,816 | - |
| 333 | CGEN | Compugen Ltd. | 149.66M | -1.84% | 149,461 | 6.90M |
| 334 | GANX | Gain Therapeutics, Inc. | 148.95M | -1.67% | 1,366,833 | - |
| 335 | PLX | Protalix BioTherapeutics, Inc. | 147.17M | 1.67% | 576,135 | 61.84M |
| 336 | INO | Inovio Pharmaceuticals, Inc. | 146.34M | -1.84% | 901,361 | 182.34K |
| 337 | ELTX | Elicio Therapeutics, Inc. | 146.27M | 3.98% | 87,459 | - |
| 338 | CGTX | Cognition Therapeutics, Inc. | 143.00M | -4.14% | 905,132 | - |
| 339 | MRSN | Mersana Therapeutics, Inc. | 141.11M | 0.43% | 33,480 | 33.18M |
| 340 | AGEN | Agenus Inc. | 138.75M | -0.24% | 246,490 | 106.83M |
| 341 | UNCY | Unicycive Therapeutics, Inc. | 137.76M | -2.73% | 302,665 | - |
| 342 | CNTB | Connect Biopharma Holdings Limited | 135.85M | 3.40% | 104,161 | 762.00K |
| 343 | PRLD | Prelude Therapeutics Incorporated | 134.31M | -1.21% | 160,198 | 10.50M |
| 344 | EXOZ | eXoZymes, Inc. | 133.36M | -0.69% | 3,248 | -700.00 |
| 345 | NKTX | Nkarta, Inc. | 132.83M | -0.53% | 452,441 | - |
| 346 | VRCA | Verrica Pharmaceuticals Inc. | 132.72M | 0.73% | 207,354 | 30.83M |
| 347 | SPRO | Spero Therapeutics, Inc. | 132.40M | 0.86% | 185,554 | 40.55M |
| 348 | COYA | Coya Therapeutics, Inc. | 130.78M | 2.63% | 245,280 | 3.99M |
| 349 | RZLT | Rezolute, Inc. | 129.82M | -87.20% | 128,724,603 | - |
| 350 | ATRA | Atara Biotherapeutics, Inc. | 128.49M | 5.88% | 102,105 | 151.93M |
| 351 | FATE | Fate Therapeutics, Inc. | 128.04M | 1.83% | 1,011,361 | 7.14M |
| 352 | ELDN | Eledon Pharmaceuticals, Inc. | 127.75M | - | 807,510 | - |
| 353 | ACOG | Alpha Cognition Inc. | 126.76M | -2.83% | 125,191 | 7.43M |
| 354 | ORMP | Oramed Pharmaceuticals Inc. | 120.80M | 4.66% | 920,330 | 2.00M |
| 355 | KPTI | Karyopharm Therapeutics Inc. | 119.36M | 8.02% | 596,439 | 142.53M |
| 356 | ABOS | Acumen Pharmaceuticals, Inc. | 118.72M | 3.16% | 156,109 | - |
| 357 | DTIL | Precision BioSciences, Inc. | 118.43M | -1.80% | 180,894 | 698.00K |
| 358 | SLGL | Sol-Gel Technologies Ltd. | 117.84M | - | 10,192 | 18.97M |
| 359 | WHWK | Whitehawk Therapeutics, Inc. | 117.82M | -3.47% | 154,644 | 14.38M |
| 360 | OVID | Ovid Therapeutics Inc. | 117.50M | 1.85% | 1,415,823 | 6.61M |
| 361 | ATOS | Atossa Therapeutics, Inc. | 116.87M | 6.45% | 5,824,334 | - |
| 362 | CNTX | Context Therapeutics Inc. | 110.85M | -2.80% | 534,541 | - |
| 363 | BMEA | Biomea Fusion, Inc. | 107.47M | -1.30% | 2,163,668 | - |
| 364 | ONCY | Oncolytics Biotech Inc. | 105.98M | 0.89% | 313,366 | - |
| 365 | ZNTL | Zentalis Pharmaceuticals, Inc. | 104.76M | 2.11% | 241,552 | 26.87M |
| 366 | VANI | Vivani Medical, Inc. | 101.40M | -6.08% | 272,952 | - |
| 367 | ENTX | Entera Bio Ltd. | 101.34M | 4.25% | 51,940 | 124.00K |
| 368 | SEER | Seer, Inc. | 100.98M | -1.09% | 221,027 | 16.38M |
| 369 | ANVS | Annovis Bio, Inc. | 100.45M | -9.76% | 1,487,011 | - |
| 370 | PSTV | Plus Therapeutics, Inc. | 98.95M | 7.11% | 6,964,654 | 5.26M |
| 371 | SPRB | Spruce Biosciences, Inc. | 94.63M | 3.20% | 71,486 | 697.00K |
| 372 | TTRX | Turn Therapeutics Inc. | 94.52M | 5.25% | 66,516 | - |
| 373 | CBUS | Cibus, Inc. | 94.45M | 4.82% | 212,180 | 3.79M |
| 374 | ANEB | Anebulo Pharmaceuticals, Inc. | 92.03M | 4.19% | 20,946 | - |
| 375 | RPTX | Repare Therapeutics Inc. | 91.99M | -0.47% | 1,538,642 | 11.87M |
| 376 | FBIO | Fortress Biotech, Inc. | 91.25M | - | 177,766 | 62.30M |
| 377 | BYSI | BeyondSpring Inc. | 89.65M | 7.92% | 97,783 | 1.88M |
| 378 | MGNX | MacroGenics, Inc. | 89.19M | 0.71% | 1,049,956 | 127.63M |
| 379 | OTLK | Outlook Therapeutics, Inc. | 88.84M | -4.31% | 2,169,683 | 1.51M |
| 380 | THAR | Tharimmune, Inc. | 88.66M | -5.95% | 380,928 | - |
| 381 | VXRT | Vaxart, Inc. | 87.44M | 0.27% | 866,180 | 148.20M |
| 382 | CSBR | Champions Oncology, Inc. | 86.87M | 2.27% | 3,857 | 56.88M |
| 383 | COEP | Coeptis Therapeutics Holdings, Inc. | 86.72M | 7.91% | 113,651 | 501.00K |
| 384 | HYFT | MindWalk Holdings Corp. | 86.31M | -0.53% | 121,986 | 18.21M |
| 385 | TVGN | Tevogen Bio Holdings Inc. | 85.44M | -1.78% | 779,003 | - |
| 386 | ACET | Adicet Bio, Inc. | 83.57M | -5.81% | 3,629,927 | - |
| 387 | STRO | Sutro Biopharma, Inc. | 83.52M | 9.00% | 86,172 | 105.65M |
| 388 | ADAG | Adagene Inc. | 83.14M | -2.54% | 37,905 | 103.20K |
| 389 | ALXO | ALX Oncology Holdings Inc. | 82.41M | -1.30% | 85,627 | - |
| 390 | ACRV | Acrivon Therapeutics, Inc. | 82.36M | -0.38% | 367,459 | - |
| 391 | EQ | Equillium, Inc. | 81.60M | 25.23% | 1,219,385 | 4.39M |
| 392 | OKYO | OKYO Pharma Limited | 81.24M | 6.93% | 897,360 | - |
| 393 | PLRX | Pliant Therapeutics, Inc. | 81.11M | 3.13% | 729,015 | - |
| 394 | IMUX | Immunic, Inc. | 78.91M | -3.95% | 2,199,650 | - |
| 395 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 78.11M | -7.00% | 6,758,720 | - |
| 396 | XBIT | XBiotech Inc. | 77.74M | -0.39% | 77,822 | - |
| 397 | ARTV | Artiva Biotherapeutics, Inc. | 77.07M | 2.28% | 125,884 | 251.00K |
| 398 | CRVO | CervoMed Inc. | 75.78M | -5.54% | 35,809 | 6.16M |
| 399 | ATYR | aTyr Pharma, Inc. | 74.99M | -6.21% | 1,588,100 | 190.00K |
| 400 | KRRO | Korro Bio, Inc. | 74.40M | 0.89% | 318,388 | 7.37M |
| 401 | TIL | Instil Bio, Inc. | 74.33M | -3.78% | 54,810 | - |
| 402 | MNOV | MediciNova, Inc. | 74.06M | - | 43,149 | 257.92K |
| 403 | PTHS | Pelthos Therapeutics Inc. | 73.90M | -4.35% | 25,124 | 7.41M |
| 404 | OSTX | OS Therapies Incorporated | 71.49M | 2.01% | 517,455 | - |
| 405 | ALGS | Aligos Therapeutics, Inc. | 70.83M | 1.59% | 50,884 | 2.65M |
| 406 | ESLA | Estrella Immunopharma, Inc. | 69.87M | -11.06% | 375,681 | - |
| 407 | IFRX | InflaRx N.V. | 69.10M | -2.86% | 513,413 | 73.73K |
| 408 | IMA | ImageneBio, Inc. | 68.91M | 0.62% | 44,135 | 800.00K |
| 409 | PMVP | PMV Pharmaceuticals, Inc. | 66.51M | -0.79% | 105,582 | - |
| 410 | LITS | Lite Strategy, Inc. | 66.40M | -1.90% | 425,658 | - |
| 411 | PYPD | PolyPid Ltd. | 66.21M | -0.75% | 37,391 | - |
| 412 | CALC | CalciMedica, Inc. | 66.14M | 0.66% | 147,048 | - |
| 413 | MGX | Metagenomi, Inc. | 65.33M | -4.40% | 345,364 | 30.91M |
| 414 | ATHE | Alterity Therapeutics Limited | 65.24M | 1.79% | 4,116 | 3.57M |
| 415 | NRXP | NRx Pharmaceuticals, Inc. | 61.81M | -0.45% | 406,719 | 242.00K |
| 416 | IOBT | IO Biotech, Inc. | 61.16M | 4.95% | 547,265 | - |
| 417 | MAIA | MAIA Biotechnology, Inc. | 60.73M | 18.84% | 3,461,063 | - |
| 418 | TCRX | TScan Therapeutics, Inc. | 60.72M | 3.88% | 263,846 | 8.42M |
| 419 | NTRB | Nutriband Inc. | 59.54M | 1.33% | 70,785 | 2.28M |
| 420 | INKT | MiNK Therapeutics, Inc. | 58.91M | -1.49% | 12,911 | - |
| 421 | INMB | INmune Bio, Inc. | 56.89M | -4.04% | 499,644 | 50.00K |
| 422 | PDSB | PDS Biotechnology Corporation | 55.27M | -0.98% | 497,350 | - |
| 423 | ICCC | ImmuCell Corporation | 54.91M | 3.41% | 23,712 | 27.77M |
| 424 | IBIO | iBio, Inc. | 54.42M | -13.88% | 9,843,657 | 500.00K |
| 425 | EVAX | Evaxion A/S | 53.55M | 1.26% | 56,717 | 7.65M |
| 426 | HURA | TuHURA Biosciences, Inc. | 53.05M | 0.49% | 753,401 | - |
| 427 | ABVC | ABVC BioPharma, Inc. | 53.03M | 0.90% | 72,223 | 797.92K |
| 428 | HOWL | Werewolf Therapeutics, Inc. | 52.91M | 1.87% | 457,135 | 1.14M |
| 429 | CVM | CEL-SCI Corporation | 51.94M | -0.77% | 43,001 | - |
| 430 | IPSC | Century Therapeutics, Inc. | 51.65M | - | 1,042,300 | 113.34M |
| 431 | JSPR | Jasper Therapeutics, Inc. | 51.49M | -1.60% | 546,395 | - |
| 432 | IBO | Impact BioMedical Inc. | 51.07M | -2.38% | 31,184 | 25.00K |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 50.88M | 4.96% | 486,599 | - |
| 434 | GRCE | Grace Therapeutics, Inc. | 47.47M | -0.88% | 29,545 | - |
| 435 | CELU | Celularity Inc. | 47.31M | -6.70% | 43,438 | 40.58M |
| 436 | ANL | Adlai Nortye Ltd. | 47.23M | 6.67% | 46,365 | 1.94M |
| 437 | PTN | Palatin Technologies, Inc. | 47.18M | -3.71% | 116,758 | 8.85M |
| 438 | KZR | Kezar Life Sciences, Inc. | 46.14M | -0.79% | 18,354 | - |
| 439 | BCAB | BioAtla, Inc. | 46.05M | 1.23% | 608,594 | 11.00M |
| 440 | BTAI | BioXcel Therapeutics, Inc. | 45.27M | -5.48% | 491,242 | 752.00K |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 45.23M | 2.11% | 88,163 | 90.00K |
| 442 | OKUR | OnKure Therapeutics, Inc. | 43.76M | -6.92% | 131,269 | - |
| 443 | TVRD | Tvardi Therapeutics, Inc. | 42.12M | -0.88% | 81,905 | - |
| 444 | LTRN | Lantern Pharma Inc. | 41.83M | -2.09% | 52,596 | - |
| 445 | VERU | Veru Inc. | 41.09M | -0.39% | 77,286 | 16.89M |
| 446 | JUNS | Jupiter Neurosciences, Inc. | 40.62M | 4.42% | 106,412 | - |
| 447 | RNTX | Rein Therapeutics Inc. | 40.48M | 3.36% | 190,121 | - |
| 448 | QTTB | Q32 Bio Inc. | 39.13M | -4.79% | 353,856 | - |
| 449 | CUE | Cue Biopharma, Inc. | 38.83M | 3.33% | 437,772 | 7.10M |
| 450 | XCUR | Exicure, Inc. | 38.69M | 14.10% | 580,539 | 500.00K |
| 451 | GNTA | Genenta Science S.p.A. | 38.66M | -5.71% | 69,122 | - |
| 452 | NXTC | NextCure, Inc. | 38.59M | -2.57% | 32,435 | - |
| 453 | GLTO | Galecto, Inc. | 38.50M | -1.49% | 166,235 | - |
| 454 | QNTM | Quantum BioPharma Ltd. | 38.09M | -7.26% | 78,997 | - |
| 455 | XLO | Xilio Therapeutics, Inc. | 37.29M | -1.09% | 705,378 | 31.80M |
| 456 | SNTI | Senti Biosciences, Inc. | 37.20M | -5.03% | 1,899,396 | - |
| 457 | SKYE | Skye Bioscience, Inc. | 36.87M | 0.88% | 104,276 | - |
| 458 | RNXT | RenovoRx, Inc. | 36.39M | 1.64% | 190,273 | 928.00K |
| 459 | GBIO | Generation Bio Co. | 36.32M | -2.18% | 47,318 | 15.27M |
| 460 | APLM | Apollomics, Inc. | 35.86M | -6.28% | 24,282 | 198.00K |
| 461 | INTS | Intensity Therapeutics, Inc. | 35.44M | 7.27% | 4,210,624 | - |
| 462 | RADX | Radiopharm Theranostics Limited | 35.38M | - | 9,849 | 8.20M |
| 463 | FGEN | FibroGen, Inc. | 35.20M | -1.36% | 12,197 | 8.30M |
| 464 | PASG | Passage Bio, Inc. | 33.95M | 2.59% | 41,168 | - |
| 465 | SER | Serina Therapeutics, Inc. | 33.49M | -2.18% | 12,186 | 116.00K |
| 466 | DYAI | Dyadic International, Inc. | 33.42M | -6.71% | 385,159 | 3.34M |
| 467 | ANTX | AN2 Therapeutics, Inc. | 32.75M | 1.27% | 38,861 | - |
| 468 | RLYB | Rallybio Corporation | 31.32M | -3.70% | 168,173 | 674.00K |
| 469 | APLT | Applied Therapeutics, Inc. | 31.30M | -1.41% | 9,286,469 | 1.00M |
| 470 | KLTO | Klotho Neurosciences, Inc. | 30.77M | -3.26% | 500,798 | - |
| 471 | IGC | IGC Pharma, Inc. | 30.45M | -4.12% | 971,706 | 1.11M |
| 472 | DARE | Daré Bioscience, Inc. | 29.86M | 5.03% | 427,831 | -57.13K |
| 473 | BRNS | Barinthus Biotherapeutics plc | 29.13M | 1.35% | 177,430 | 14.97M |
| 474 | PLUR | Pluri Inc. | 28.59M | -12.71% | 121,699 | 1.33M |
| 475 | NERV | Minerva Neurosciences, Inc. | 28.53M | 4.35% | 57,761 | - |
| 476 | CING | Cingulate Inc. | 28.24M | 5.82% | 209,894 | - |
| 477 | NRXS | NeurAxis, Inc. | 28.02M | -4.71% | 44,759 | 3.36M |
| 478 | LEXX | Lexaria Bioscience Corp. | 27.34M | 6.03% | 149,135 | 705.92K |
| 479 | LNAI | Lunai Bioworks Inc. | 27.18M | -2.52% | 160,177 | - |
| 480 | HYPD | Hyperion DeFi, Inc. | 27.07M | -1.31% | 109,184 | 345.32K |
| 481 | BOLD | Boundless Bio, Inc. | 25.74M | -0.86% | 72,369 | - |
| 482 | KTTA | Pasithea Therapeutics Corp. | 25.09M | -3.45% | 429,489 | - |
| 483 | ITRM | Iterum Therapeutics plc | 24.78M | 2.04% | 325,587 | 390.00K |
| 484 | PLRZ | Polyrizon Ltd. | 24.49M | 11.46% | 493,669 | - |
| 485 | CLGN | CollPlant Biotechnologies Ltd. | 24.28M | 4.97% | 31,564 | 2.48M |
| 486 | KZIA | Kazia Therapeutics Limited | 24.00M | 2.19% | 86,295 | 1.20M |
| 487 | LIXT | Lixte Biotechnology Holdings, Inc. | 23.96M | -0.47% | 125,787 | - |
| 488 | MRKR | Marker Therapeutics, Inc. | 23.68M | -2.07% | 203,700 | 4.69M |
| 489 | NNVC | NanoViricides, Inc. | 23.40M | -1.52% | 295,701 | - |
| 490 | LIMN | Liminatus Pharma, Inc. | 23.33M | -3.45% | 58,642 | - |
| 491 | ENLV | Enlivex Therapeutics Ltd. | 23.30M | -0.10% | 989,413 | - |
| 492 | CVKD | Cadrenal Therapeutics, Inc. | 22.83M | -0.99% | 182,418 | - |
| 493 | NRSN | NeuroSense Therapeutics Ltd. | 22.29M | 1.71% | 333,687 | - |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 21.43M | -0.85% | 289,594 | - |
| 495 | NEUP | Neuphoria Therapeutics Inc. | 21.40M | -5.46% | 341,145 | 15.65M |
| 496 | FBLG | FibroBiologics, Inc. | 21.31M | 4.82% | 1,491,756 | - |
| 497 | APVO | Aptevo Therapeutics Inc. | 19.55M | -3.33% | 1,266,022 | - |
| 498 | BCTX | BriaCell Therapeutics Corp. | 19.51M | -8.84% | 85,024 | - |
| 499 | GDTC | CytoMed Therapeutics Limited | 19.27M | 7.26% | 32,598 | 573.19K |
| 500 | CASI | CASI Pharmaceuticals, Inc. | 19.21M | 10.85% | 39,216 | 26.85M |
| 501 | PMN | ProMIS Neurosciences, Inc. | 18.84M | -3.79% | 16,995 | - |
| 502 | MTVA | MetaVia Inc. | 18.84M | -10.37% | 72,529 | - |
| 503 | HOTH | Hoth Therapeutics, Inc. | 18.77M | - | 88,485 | - |
| 504 | TRAW | Traws Pharma, Inc. | 18.62M | -5.67% | 129,576 | 2.85M |
| 505 | ALLR | Allarity Therapeutics, Inc. | 18.18M | -1.71% | 78,732 | - |
| 506 | LSTA | Lisata Therapeutics, Inc. | 18.12M | -0.29% | 20,702 | 1.07M |
| 507 | LPCN | Lipocine Inc. | 17.66M | -3.64% | 17,793 | 4.32M |
| 508 | KAPA | Kairos Pharma, Ltd. | 16.87M | -3.57% | 98,904 | - |
| 509 | NCNA | NuCana plc | 16.86M | -5.15% | 73,430 | - |
| 510 | OSRH | OSR Holdings, Inc. | 16.70M | 0.22% | 425,727 | -90.52K |
| 511 | CRIS | Curis, Inc. | 16.68M | -0.77% | 66,057 | 11.65M |
| 512 | SNGX | Soligenix, Inc. | 16.44M | 1.87% | 364,103 | 2.34K |
| 513 | ABP | Abpro Holdings, Inc. | 16.11M | 2.24% | 19,603 | 183.00K |
| 514 | CLRB | Cellectar Biosciences, Inc. | 16.03M | -5.97% | 40,057 | - |
| 515 | CANF | Can-Fite BioPharma Ltd. | 15.97M | -6.74% | 789,796 | 560.00K |
| 516 | BCDA | BioCardia, Inc. | 15.60M | - | 50,942 | 3.00K |
| 517 | ATHA | Athira Pharma, Inc. | 15.58M | -0.25% | 20,486 | - |
| 518 | TPST | Tempest Therapeutics, Inc. | 15.57M | 0.32% | 36,328 | - |
| 519 | PCSA | Processa Pharmaceuticals, Inc. | 15.41M | -1.77% | 1,086,523 | - |
| 520 | NCEL | NewcelX Ltd. | 15.18M | -21.83% | 238,241 | - |
| 521 | AKTX | Akari Therapeutics, Plc | 14.65M | 7.87% | 362,597 | - |
| 522 | COCP | Cocrystal Pharma, Inc. | 14.61M | -0.93% | 36,090 | - |
| 523 | CMMB | Chemomab Therapeutics Ltd. | 14.53M | -4.45% | 60,045 | - |
| 524 | PULM | Pulmatrix, Inc. | 14.46M | 0.25% | 5,990 | 3.00K |
| 525 | BLRX | BioLineRx Ltd. | 13.83M | -2.42% | 14,943 | 12.74M |
| 526 | VYNE | VYNE Therapeutics Inc. | 13.48M | 0.27% | 1,016,214 | 524.00K |
| 527 | LGVN | Longeveron Inc. | 13.38M | -0.03% | 147,178 | 1.44M |
| 528 | SYBX | Synlogic, Inc. | 12.87M | 1.85% | 35,163 | 8.00K |
| 529 | IMNN | Imunon, Inc. | 12.68M | -1.20% | 28,604 | - |
| 530 | EDSA | Edesa Biotech, Inc. | 12.46M | 0.57% | 39,484 | - |
| 531 | ICU | SeaStar Medical Holding Corporation | 12.29M | 0.29% | 509,246 | 881.00K |
| 532 | PHIO | Phio Pharmaceuticals Corp. | 12.27M | -2.56% | 122,869 | - |
| 533 | ERNA | Ernexa Therapeutics Inc. | 11.62M | 15.62% | 90,415 | 1,000.00 |
| 534 | GOVX | GeoVax Labs, Inc. | 11.52M | -2.05% | 767,960 | 3.35M |
| 535 | BIVI | BioVie Inc. | 11.38M | -4.43% | 25,561 | - |
| 536 | SNSE | Sensei Biotherapeutics, Inc. | 11.35M | 5.02% | 41,768 | - |
| 537 | BOLT | Bolt Biotherapeutics, Inc. | 11.25M | 1.03% | 8,523 | 5.20M |
| 538 | ASBP | Aspire Biopharma Holdings, Inc. | 11.23M | 22.51% | 33,933,667 | 1.94K |
| 539 | APM | Aptorum Group Limited | 10.83M | -1.48% | 24,911 | - |
| 540 | PPCB | Propanc Biopharma, Inc. | 10.78M | -0.51% | 72,942 | - |
| 541 | CLDI | Calidi Biotherapeutics, Inc. | 10.76M | -2.00% | 55,283 | - |
| 542 | GRDX | GridAI Technologies Corp. | 10.52M | 20.38% | 166,532 | - |
| 543 | MBRX | Moleculin Biotech, Inc. | 10.18M | 3.52% | 311,110 | - |
| 544 | BRTX | BioRestorative Therapies, Inc. | 9.76M | - | 24,927 | 383.40K |
| 545 | EVGN | Evogene Ltd. | 9.68M | -0.91% | 18,624 | 8.02M |
| 546 | RNAZ | TransCode Therapeutics, Inc. | 9.55M | 20.74% | 88,500 | - |
| 547 | QNRX | Quoin Pharmaceuticals, Ltd. | 9.53M | -4.70% | 39,536 | - |
| 548 | TCRT | Alaunos Therapeutics, Inc. | 9.53M | -0.93% | 36,526 | 6.00K |
| 549 | SLXN | Silexion Therapeutics Corp | 9.50M | 0.66% | 47,480 | - |
| 550 | AEON | AEON Biopharma, Inc. | 9.00M | -0.65% | 143,441 | - |
| 551 | MBIO | Mustang Bio, Inc. | 8.90M | -2.40% | 57,159 | - |
| 552 | ACXP | Acurx Pharmaceuticals, Inc. | 8.57M | -4.20% | 48,660 | - |
| 553 | ALZN | Alzamend Neuro, Inc. | 8.29M | 0.93% | 48,309 | - |
| 554 | CELZ | Creative Medical Technology Holdings, Inc. | 8.24M | 1.83% | 55,686 | 6.00K |
| 555 | XTLB | XTL Biopharmaceuticals Ltd. | 8.24M | 1.98% | 18,990 | 451.00K |
| 556 | ADXN | Addex Therapeutics Ltd | 8.22M | 6.72% | 4,560 | 198.82K |
| 557 | PPBT | Purple Biotech Ltd | 8.11M | -0.45% | 10,687,692 | - |
| 558 | INAB | IN8bio, Inc. | 8.02M | -2.26% | 32,085 | - |
| 559 | KPRX | Kiora Pharmaceuticals, Inc. | 7.85M | 0.94% | 42,936 | 20.00K |
| 560 | TOVX | Theriva Biologics, Inc. | 7.85M | 5.01% | 2,065,414 | - |
| 561 | KALA | KALA BIO, Inc. | 7.46M | -9.75% | 2,869,861 | - |
| 562 | GNPX | Genprex, Inc. | 7.36M | -2.70% | 104,195 | - |
| 563 | BGMS | Bio Green Med Solution, Inc. | 7.35M | 0.67% | 20,615 | 81.00K |
| 564 | ADIL | Adial Pharmaceuticals, Inc. | 7.13M | -3.88% | 134,367 | - |
| 565 | LYRA | Lyra Therapeutics, Inc. | 7.10M | -0.74% | 7,892 | 600.00K |
| 566 | IMRN | Immuron Limited | 7.04M | -6.25% | 252,529 | 4.78M |
| 567 | PMCB | PharmaCyte Biotech, Inc. | 6.93M | -1.92% | 1,494,885 | - |
| 568 | GTBP | GT Biopharma, Inc. | 6.91M | -3.35% | 1,027,113 | - |
| 569 | REVB | Revelation Biosciences, Inc. | 6.81M | 5.50% | 237,988 | - |
| 570 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.76M | -1.86% | 7,436 | 15.78K |
| 571 | CYCN | Cyclerion Therapeutics, Inc. | 6.39M | -2.33% | 38,482 | 2.86M |
| 572 | APRE | Aprea Therapeutics, Inc. | 5.96M | 3.60% | 123,386 | 488.24K |
| 573 | SILO | Silo Pharma, Inc. | 5.92M | 1.07% | 70,865 | 72.10K |
| 574 | JAGX | Jaguar Health, Inc. | 5.90M | 8.27% | 440,126 | 11.79M |
| 575 | VIVS | VivoSim Labs, Inc. | 5.89M | -3.83% | 38,908 | 140.00K |
| 576 | GLMD | Galmed Pharmaceuticals Ltd. | 5.64M | -2.83% | 134,871 | - |
| 577 | XBIO | Xenetic Biosciences, Inc. | 5.54M | 0.83% | 31,127 | 2.86M |
| 578 | HCWB | HCW Biologics Inc. | 5.32M | -1.50% | 45,887 | 422.03K |
| 579 | ENSC | Ensysce Biosciences, Inc. | 5.16M | -10.13% | 282,940 | 4.49M |
| 580 | MTNB | Matinas BioPharma Holdings, Inc. | 5.08M | 0.37% | 38,866 | - |
| 581 | CNSP | CNS Pharmaceuticals, Inc. | 4.75M | 1.65% | 12,865 | - |
| 582 | SLRX | Salarius Pharmaceuticals, Inc. | 4.75M | -6.71% | 401,945 | - |
| 583 | INDP | Indaptus Therapeutics, Inc. | 4.50M | -3.02% | 10,956 | - |
| 584 | CMND | Clearmind Medicine Inc. | 4.30M | -37.27% | 16,054,685 | - |
| 585 | XRTX | XORTX Therapeutics Inc. | 4.21M | 0.15% | 20,618 | - |
| 586 | SCNI | Scinai Immunotherapeutics Ltd. | 3.92M | - | 6,685 | 1.15M |
| 587 | AZTR | Azitra, Inc. | 3.92M | -4.70% | 281,882 | 7.50K |
| 588 | ARTL | Artelo Biosciences, Inc. | 3.92M | 2.11% | 81,347 | - |
| 589 | BDRX | Biodexa Pharmaceuticals Plc | 3.90M | -6.25% | 644,208 | 104.90K |
| 590 | OGEN | Oragenics, Inc. | 3.88M | -3.84% | 14,860 | - |
| 591 | PHGE | BiomX Inc. | 3.74M | -10.91% | 108,679 | - |
| 592 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.70M | -7.02% | 315,764 | 1.36M |
| 593 | ONCO | Onconetix, Inc. | 3.61M | -17.50% | 102,260 | 1.22M |
| 594 | ENVB | Enveric Biosciences, Inc. | 3.25M | -47.34% | 1,618,353 | - |
| 595 | SPRC | SciSparc Ltd. | 3.10M | -2.55% | 152,604 | 1.31M |
| 596 | ELAB | PMGC Holdings Inc. | 3.06M | -4.86% | 128,765 | 285.95K |
| 597 | PTIX | Protagenic Therapeutics, Inc. | 3.06M | -5.95% | 43,085 | - |
| 598 | CDT | CDT Equity Inc. | 2.95M | -9.05% | 195,581 | - |
| 599 | PBM | Psyence Biomedical Ltd. | 2.90M | 1.31% | 431,224 | - |
| 600 | VRAX | Virax Biolabs Group Limited | 2.90M | -9.33% | 420,945 | 2.99K |
| 601 | DRMA | Dermata Therapeutics, Inc. | 2.82M | -5.17% | 46,511 | - |
| 602 | MLEC | Moolec Science SA | 1.75M | -6.67% | 194,616 | 7.83M |
| 603 | GRI | GRI Bio, Inc. | 1.72M | -56.45% | 8,985,383 | - |
| 604 | ADTX | Aditxt, Inc. | 1.33M | -7.06% | 296,063 | 5.95K |